If u want buy on weak, buy while some traders swap from mother to PA in order to subscribe at 0.08 per pa. Uptrending still intact unless Asiabio fail to sustain above 0.190
1 thing puzzle me What will happen , if the porfolio invested faded... share price retreated rite ? Vice versa , share price up ... I treat Asiabio my Leap and Fintec fund a portfolio manager to help me screen & pick the best Investment instrument in its specialists field. I dont know how good they are, but i feel it us ok... if they can keep the performances mantain that way.
Somemore, Asiabio now at it's low tide ... i believe the reward is lot greater from here.
1st time I ever know that a company undertakes a rights issue to subscribe for another company's rights issue. Ini apa ini? Kleptocrats in action...robbers in control.
ASIABIO offer for bargain hunting opportunity during weak at range of 0.185 -0.190 , given the Fintec spectrum still exciting on the market, this New Sunshine worth your attention .
A break of 0.205 above may likely test 0.230-0.250 xp
those PR subscriber's cost is 0.17=[(0.005+0.08)x2] and they have free warrant, do you think banker make higher price to let them sell in profit , and 0.005 is the seller price on last day of ASIA-PR listing, my 2cent view
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
14888
178 posts
Posted by 14888 > 2017-11-18 23:07 | Report Abuse
asiabio投资的dgb涨了,asiabio又赚钱了